Educational Disclaimer: All content on this hub is provided for educational purposes only. It documents how integrative medical doctors, naturopathic physicians, researchers, and holistic practitioners approach cancer and chronic illness. Nothing here constitutes medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before beginning any protocol. Prescription medications require a valid prescription from a licensed provider.

Category 1: Repurposed Pharmaceuticals & Antiparasitic Agents

A growing body of integrative oncology research documents the potential of repurposed drugs — medications originally developed for other conditions — as adjunctive agents in cancer and chronic illness protocols. The following articles explore the science, practitioner perspectives, and clinical applications of these agents.

• How Repurposed Drugs Work: LDN, Ivermectin, Fenbendazole, Niclosamide & DMSO

  An overview of the mechanisms behind five of the most discussed repurposed agents in integrative oncology and chronic illness care.

• Ivermectin: Uses, Dosing Overview & Protocol Tips

  A deep dive into Ivermectin's antiparasitic and emerging immunomodulatory properties, with practitioner protocol context.

• Fenbendazole: A Broad-Spectrum Antiparasitic Deep Dive

  Exploring Fenbendazole's β-tubulin mechanism, its antiparasitic applications, and the emerging research on its broader biological activity.

• Mebendazole: Your Guide to Intestinal Parasite Treatment

  How Mebendazole works against intestinal helminths and its place in integrative antiparasitic protocols.

• Fluconazole & Itraconazole: A Guide to Antifungal Protocols

  How azole-class antifungals are used by integrative practitioners to address systemic Candida and fungal burden in chronic illness.

• Potential Benefits of DMSO: What the Research Suggests

  An educational overview of DMSO's properties, its history in integrative medicine, and what current research documents about its biological activity.

• Low Dose Naltrexone (LDN): Immune Modulation & Integrative Applications

  Dr. Bernard Bihari's foundational work, immune modulation mechanisms, and clinical applications in cancer and autoimmune disease.

• Niclosamide: Repurposed Antiparasitic & Emerging Oncology Agent

  STAT3 inhibition, Wnt pathway disruption, and the growing research base for Niclosamide in integrative oncology protocols.

Category 2: Parasites, Pathogens & Detoxification

Integrative practitioners increasingly recognize the role of parasitic burden, heavy metal accumulation, and biofilm-protected pathogens as hidden drivers of chronic illness and immune dysfunction. These articles explore the science and clinical protocols for addressing these root causes.

• Parasites and Other Bloodsuckers: A Comprehensive Guide

  The Dr. Lodi antiparasitic protocol, botanical alternatives, homeopathic approaches, and practitioner perspectives with PubMed citations.

• Understanding Antiparasitic Protocols: Supporting Your Body's Natural Defense

  A foundational guide to how antiparasitic protocols work and how to approach them safely.

• Heavy Metals: Not the Metallica or Black Sabbath Types

  How heavy metal accumulation creates a refuge for pathogens and parasites, and how detoxification supports immune restoration.

• Binders: What They Are, How They Work & How to Use Them Safely

  A guide to binding agents — activated charcoal, chlorella, zeolite, MCP — and their role in detoxification protocols.

• The Herxheimer Reaction: Why You Feel Worse Before You Feel Better

  Understanding die-off reactions, how to manage them, and why they signal that a protocol is working.

• Biofilm & Cancer: The Hidden Pathogen Connection

  Emerging research connecting biofilm-forming bacteria to tumor microenvironments and chronic immune suppression.

• Detox Pathways & Cancer Prevention: Liver Phase I/II, Glutathione & NRF2

  How optimizing detoxification pathways supports cancer prevention and immune resilience.

Category 3: Metabolic Theory of Cancer

A paradigm-shifting body of research — rooted in Otto Warburg's Nobel Prize-winning work and advanced by researchers like Dr. Thomas Seyfried — proposes that cancer is fundamentally a metabolic disease driven by mitochondrial dysfunction and aberrant energy metabolism, not simply a genetic one.

• Fasting & Cancer: Differential Stress Resistance

  How fasting selectively starves cancer cells while protecting healthy tissue — the science of differential stress resistance and Dr. Valter Longo's research.

• Mitochondrial Dysfunction & Chronic Fatigue: Root Causes

  The connection between mitochondrial dysfunction, energy failure, and the cellular environment that enables disease progression.

• The Metabolic Theory of Cancer: Warburg, Seyfried & Beyond Coming Soon

  Otto Warburg's original hypothesis, Dr. Thomas Seyfried's press-pulse strategy, and the implications for integrative cancer care.

• The Ketogenic Diet & Cancer: Starving the Tumor Coming Soon

  Dr. Dominic D'Agostino's research, the press-pulse metabolic strategy, and clinical trials on ketogenic diets in oncology.

Category 4: Botanical & Integrative Therapies

From high-dose Vitamin C to mistletoe therapy, integrative oncology draws on a rich tradition of plant-based and natural therapies with growing research support. These articles document how practitioners use these agents alongside conventional and repurposed pharmaceutical approaches.

• Berberine HCL: Gut Health & Metabolic Support

  Berberine's antifungal, antiparasitic, and metabolic properties — and its role in integrative protocols for gut dysbiosis and metabolic dysfunction.

• Quercetin: Immune Support & Anti-Inflammatory Properties

  How quercetin functions as a zinc ionophore, senolytic agent, and anti-inflammatory compound in integrative health protocols.

• Supplement Stacking Guide: Synergistic Combinations for Inflammation, Immunity & Cellular Health

  How to combine supplements strategically for maximum synergistic effect across inflammation, immunity, and cellular health.

• Mistletoe (Iscador) Therapy: Europe's Integrative Oncology Standard Coming Soon

  Dr. Rudolf Steiner's origins, European clinical use, NIH-funded trials, and how integrative oncologists incorporate mistletoe therapy.

• High-Dose Vitamin C in Cancer Care: IV vs. Oral & the Riordan Protocol Coming Soon

  Linus Pauling's foundational research, the Riordan Clinic IV-C protocol, and current NIH-funded clinical trials.

• Hyperthermia & Fever Therapy: Activating the Immune System Coming Soon

  Dr. Josef Issels' whole-body hyperthermia approach, fever therapy history, and modern clinical applications in integrative oncology.

Category 5: The Mind-Body-Spirit Dimension

Integrative oncology recognizes that healing is not purely biochemical. The emotional, psychological, and spiritual dimensions of illness — documented by researchers in psychoneuroimmunology and pioneering clinicians like Dr. Bernie Siegel — play a measurable role in immune function, treatment response, and recovery.

• The Emotional & Psychological Roots of Cancer: Psychoneuroimmunology & Healing Coming Soon

  Dr. Ryke Geerd Hamer, Dr. Bernie Siegel, and the psychoneuroimmunology research connecting emotional trauma, stress, and immune suppression to disease onset.

Category 6: Clinical Tools & Protocol Support

Understanding how to read your labs, manage detox reactions, and interpret drug information is essential to navigating integrative protocols safely and effectively.

• Blood Work Explained: What to Look For, Warning Signs, Facts & Myths

  How to interpret your lab results, what markers matter most in integrative protocols, and common misconceptions about blood work.

• Drug Expiration Dates: What They Really Mean for Potency, Safety & Storage

  The science behind expiration dating, what the research says about drug stability, and how to store medications properly.

• Doxycycline & Azithromycin: An Antibiotic Overview

  How these antibiotics are used in integrative protocols for tick-borne illness, chronic infection, and co-infection management.